These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14767572)

  • 21. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
    Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
    Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines.
    Ku JL; Kang SB; Shin YK; Kang HC; Hong SH; Kim IJ; Shin JH; Han IO; Park JG
    Oncogene; 2004 Sep; 23(40):6736-42. PubMed ID: 15273736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer.
    Wang J; Lee JJ; Wang L; Liu DD; Lu C; Fan YH; Hong WK; Mao L
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6119-25. PubMed ID: 15447998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.
    Aggerholm A; Holm MS; Guldberg P; Olesen LH; Hokland P
    Eur J Haematol; 2006 Jan; 76(1):23-32. PubMed ID: 16343268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
    Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D
    Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
    Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung.
    Kim YT; Park SJ; Lee SH; Kang HJ; Hahn S; Kang CH; Sung SW; Kim JH
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1378. PubMed ID: 16256792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer.
    Gu J; Berman D; Lu C; Wistuba II; Roth JA; Frazier M; Spitz MR; Wu X
    Clin Cancer Res; 2006 Dec; 12(24):7329-38. PubMed ID: 17189404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
    Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
    Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
    Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D
    Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.
    Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasis.
    Chen J; Röcken C; Lofton-Day C; Schulz HU; Müller O; Kutzner N; Malfertheiner P; Ebert MP
    Carcinogenesis; 2005 Jan; 26(1):37-43. PubMed ID: 15375009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation.
    Pilozzi E; Onelli MR; Ziparo V; Mercantini P; Ruco L
    J Pathol; 2004 Nov; 204(3):289-95. PubMed ID: 15378566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancer.
    Müller HM; Widschwendter A; Fiegl H; Goebel G; Wiedemair A; Müller-Holzner E; Marth C; Widschwendter M
    Cancer Lett; 2004 Jun; 209(2):231-6. PubMed ID: 15159026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
    J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.
    Mandelker DL; Yamashita K; Tokumaru Y; Mimori K; Howard DL; Tanaka Y; Carvalho AL; Jiang WW; Park HL; Kim MS; Osada M; Mori M; Sidransky D
    Cancer Res; 2005 Jun; 65(11):4963-8. PubMed ID: 15930319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma.
    Hou P; Ji M; Yang B; Chen Z; Qiu J; Shi X; Lu Z
    Cancer; 2006 Apr; 106(7):1602-9. PubMed ID: 16502411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
    Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?
    Kim YT; Lee SH; Sung SW; Kim JH
    Ann Thorac Surg; 2005 Apr; 79(4):1180-8; discussion 1180-8. PubMed ID: 15797047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.